Jacobs Levy Equity Management, Inc Fate Therapeutics Inc Transaction History

Jacobs Levy Equity Management, Inc

$24.2 Billion
Q2 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,213,736 shares of FATE stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,213,736

Previous 2,203,323 44.91%

Holding current value

$1.17 Million

Previous $1.74 Million 21.9%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.68 - $1.67 $672,919 - $1.65 Million	-989,587 Reduced 44.91%	1,213,736 $1.36 Million
Q1 2025 May 15, 2025	BUY	$0.79 - $1.87 $486,905 - $1.15 Million	616,336 Added 38.84%	2,203,323 $1.74 Million
Q4 2024 Feb 14, 2025	SELL	$1.61 - $3.35 $1,469 - $3,058	-913 Reduced 0.06%	1,586,987 $2.62 Million
Q3 2024 Nov 14, 2024	SELL	$3.12 - $5.57 $331,709 - $592,185	-106,317 Reduced 6.28%	1,587,900 $5.56 Million
Q2 2024 Aug 14, 2024	SELL	$3.26 - $7.08 $996,272 - $2.16 Million	-305,605 Reduced 15.28%	1,694,217 $5.56 Million
Q1 2024 May 15, 2024	SELL	$3.54 - $8.35 $2.18 Million - $5.15 Million	-616,998 Reduced 23.58%	1,999,822 $14.7 Million
Q4 2023 Feb 14, 2024	BUY	$1.65 - $3.94 $375,700 - $897,126	227,697 Added 9.53%	2,616,820 $9.79 Million
Q3 2023 Nov 16, 2023	BUY	$2.02 - $5.04 $109,090 - $272,185	54,005 Added 2.31%	2,389,123 $5.06 Million
Q2 2023 Aug 14, 2023	BUY	$4.76 - $6.59 $4.72 Million - $6.53 Million	991,489 Added 73.79%	2,335,118 $11.1 Million
Q1 2023 May 15, 2023	BUY	$4.24 - $11.12 $5.7 Million - $14.9 Million	1,343,629 New	1,343,629 $7.66 Million
Q4 2017 Feb 13, 2018	SELL	$3.94 - $6.64 $64,222 - $108,232	-16,300 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$2.6 - $4.31 $87,630 - $145,264	-33,704 Reduced 67.4%	16,300 $65,000
Q2 2017 Nov 09, 2017	BUY	N/A	50,004	50,004 $162,000

Others Institutions Holding FATE

# of Institutions

150

Shares Held

83.4M

Call Options Held

179K

Put Options Held

13.4K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $93.1M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Fate Therapeutics Inc Transaction History